StockVS

NASDAQ · Medical Devices · USD

Sintx Technologies, Inc. (SINT) Stock Analysis

Sintx Technologies, Inc. (SINT) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

SINT

$1.63

+$0.09 (+5.84%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare SINT with… →

SINT Key Statistics

As of Sep 4, 2026
Trading
Open
$1.54
Previous Close
$1.54
Day's Range
1.51–1.69
52-Week Range
1.40–5.14
Volume
43.70K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.64
Valuation
Market Cap
$10.86M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
8.17
EPS (ttm)Profit attributable to each share over the last twelve months.
−5.48
Financials (FY)
Revenue (FY)
$729.00K−41.49%
Net Income (FY)
−$10.36M
Profit marginThe share of revenue left as profit after all costs and taxes.
0.00%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
6.66M
1-Year Return
−62.79%
Dividend and dates
Avg Volume
101.90K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

SINT Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−57.77%
2025+10.29%
2024−95.41%
2023−96.06%
2022−84.92%
2021−59.11%
2020+5.37%
2019−72.41%
2018−94.50%
2017−56.75%
2016 (partial year)−24.10%

As of September 4, 2026.

SINT Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$729.00K−$10.36M−1421.7%
2024$1.25M−$11.02M−884.8%
2023$1.23M−$8.26M−673.7%
2022$601.00K−$12.04M−2003.2%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$729.00K$172.00K−$10.72M−$10.36M−1421.7%
2024$1.25M$435.00K−$9.04M−$11.02M−884.8%
2023$1.23M$442.00K−$13.36M−$8.26M−673.7%
2022$601.00K$336.00K−$11.34M−$12.04M−2003.2%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

SINT Valuation vs Medical Devices Median

Median of 151 stocks
MetricSINTMedical Devices medianvs median
P/S ratio8.172.98174% above
Profit margin0.00%−1.69%1.7 pts above

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Sintx Technologies, Inc. (SINT) at $10.86M. The company sits in the Healthcare sector, in the Medical Devices industry. The company reports 32 employees.

The most recent close on file for SINT is $1.63, dated September 4, 2026. That is +$0.09 (+5.84%) against the previous close. Over the past 52 weeks the price has ranged from $1.40 to $5.14. The latest close sits 16.43% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $729.00K. That is −41.49% against the prior fiscal year, when revenue was $1.25M. The same year closed with a net loss of $10.36M. The reported profit margin is 0%. That is 1.7 percentage points above the Medical Devices median of −1.69%. Earnings per share on a trailing basis come to −5.48.

Across the 4 fiscal years on file, revenue moves from $601.00K in 2022 to $729.00K in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. Measured against sales, the shares trade at 8.17 times revenue. On price-to-sales that is 174.45% above the Medical Devices median of 2.98. 151 Medical Devices companies report these metrics, and the medians quoted come from that group.

The trailing one-year price return is −62.79%. Measured over 10 years, that is −78.02% a year compounded. Beta against the wider market is reported at 0.64. Daily returns over the trailing 10 years annualize to a volatility of 150.81%.

Growth & Income

The record shows no dividend for SINT.

Across the complete calendar years on file, 2025 returned +10.29% and 2023 returned −96.06%. Of the 9 complete calendar years on file, 2 finished higher. 2026 is still running; the price is −57.77% year to date.

Peer Comparison

Sintx Technologies, Inc. (SINT) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Sintx Technologies, Inc. SINT $10.86M
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. Sintx Technologies, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

View all Medical Devices stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About Sintx Technologies, Inc.

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE). The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Visit website →